MedTrace Logo

A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma

NCT06656039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2024-10-24

No results posted yet for this study

Summary

The main goal of this observational study is to construct a predictive recurrence model for renal clear cell carcinoma through an artificial intelligence multimodal algorithm, which will improve the prognosis and survival time of ccRCC patients by helping clinicians to formulate individualised follow-up and to screen for appropriate adjuvant therapy candidates.

Conditions

  • Renal Cell Carcinoma, Clear Cell

Sponsors & Collaborators

  • The First Affiliated Hospital of Anhui Medical University

    collaborator OTHER

  • The Fourth Affiliated Hospital of Harbin Medical University

    collaborator OTHER

  • Second Affiliated Hospital of Soochow University

    collaborator OTHER

  • Qianfoshan Hospital

    collaborator OTHER

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • RenJi Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-10-10
Completion
2024-10-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06656039 on ClinicalTrials.gov